With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.1671-87-0,3,6-Di(pyridin-2-yl)-1,2,4,5-tetrazine,as a common compound, the synthetic route is as follows.
The reaction of 12 with 4 was monitored by UV-Vis, using a ten-fold excess of the dienophile. The reaction was conducted at 25 C. in a 1-mL UV cuvette. A 2¡Á10-5 M solution of compound 4 in THF and a 2¡Á10-4 solution of compound 12 in THF were prepared separately. A 0.5 mL portion of each solution was added to the cuvette, and measurements were taken every 10 seconds until complete consumption of 4.
The synthetic route of 1671-87-0 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; University of Delaware; US2009/23916; (2009); A1;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI